Technology in and for Society: Innovating well for inclusive transitions


Jason Kelly

Ginkgo Bioworks

Co-Founder and CEO


Dr. Jason Kelly is the co-founder and CEO of Ginkgo Bioworks. Ginkgo is a synthetic biology company headquartered in Boston, MA that programs cells for customers in the chemical, pharmaceutical, food and energy industries. The company recently raised over $930M in venture capital to expand their automated genetic engineering foundries and is the largest designer of synthetic DNA in the world. Ginkgo is valued at $4.5B and has been listed for the past three years on CNBC's Disruptor 50 List of fast-growing companies. Prior to Ginkgo, Jason received B.S. degrees in Chemical Engineering and Biology and a PhD in Biological Engineering all from MIT.

This speaker will talk about

Find here the list of all the sessions presented by this speaker in order not to miss any of it.